Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?

Nafiye Yilmaza Department of Reproductive Endocrinology, Zekai Tahir Burak Women’s Health Education and Research Hospital, University of Health Sciences, Ankara, TurkeyView further author information

Pinar Gulsen Cobanb Department of Obstetric and Gynecology, Zekai Tahir Burak Women’s Health Education and Research Hospital, University of Health Sciences, Ankara, TurkeyCorrespondence[email protected]

https://orcid.org/0000-0003-1366-5442 View further author information

Saynur Yilmazb Department of Obstetric and Gynecology, Zekai Tahir Burak Women’s Health Education and Research Hospital, University of Health Sciences, Ankara, TurkeyView further author information

Hasan Ali Inalc Department of Reproductive Endocrinology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, TurkeyView further author information

Hakan Timurb Department of Obstetric and Gynecology, Zekai Tahir Burak Women’s Health Education and Research Hospital, University of Health Sciences, Ankara, TurkeyView further author information

Hacer Haltasd Department of Pathology, Private Hospital, Ankara, TurkeyView further author information

Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date